To examine the effects of baseline Alzheimer disease and cerebrovascular disease markers on longitudinal default mode network (DMN) and executive control network (ECN) functional connectivity (FC) changes in mild cognitive impairment (MCI).
Methods
We studied 30 patients with amnestic MCI (aMCI) and 55 patients with subcortical vascular MCI (svMCI) with baseline Pittsburgh Compound B (PiB)-PET scans and longitudinal MRI scans. Participants were followed up clinically with annual MRI for up to 4 years (aMCI: 26 with 2 timepoints, 4 with 3 timepoints; svMCI: 13 with 2 timepoints, 16 with 3 timepoints, 26 with 4 timepoints).
Results β-Amyloid (Aβ) burden was associated with longitudinal DMN FC declines, while cerebrovascular burden was associated with longitudinal ECN FC changes. When patients were divided into PiB+ and PiB− groups, PiB+ patients showed longitudinal DMN FC declines, while patients with svMCI showed longitudinal ECN FC increases. Direct comparisons between the 2 groups without mixed pathology (aMCI PiB+ and svMCI PiB−) recapitulated this divergent pattern: aMCI PiB+ patients showed steeper longitudinal DMN FC declines, while svMCI PiB− patients showed steeper longitudinal ECN FC increases. Finally, using baseline PiB uptake and lacune numbers as continuous variables, baseline PiB uptake showed inverse U-shape associations with longitudinal DMN FC changes in both MCI subtypes, while baseline lacune numbers showed mainly inverse U-shape relationships with longitudinal ECN FC changes in patients with svMCI.
Conclusions
Our findings underscore the divergent effects of Aβ and cerebrovascular burden on longitudinal FC changes in the DMN and ECN in the predementia stage, which reflect the underlying pathology and may be used to track early changes in Alzheimer disease and cerebrovascular disease.
Alzheimer disease (AD) and subcortical vascular dementia are among the most common causes of late-life cognitive impairment. AD is characterized by memory dysfunction and the presence of β-amyloid (Aβ) plaques and neurofibrillary tau tangles, while subcortical vascular dementia features extensive cerebrovascular disease and frontalexecutive dysfunction. 1 Aβ deposition and cerebrovascular disease commonly coexist in patients with cognitive impairment, and evidence from autopsy and neuroimaging studies suggests that these 2 pathologies independently contribute to brain structural degradation and cognitive decline. [2] [3] [4] [5] [6] [7] [8] [9] Autopsy studies, for example, reported patients with AD and cerebrovascular disease to show lower AD burden than those without cerebrovascular disease given the same dementia severity. 7, 8 Correspondingly, neuroimaging studies have demonstrated that Aβ and cerebrovascular disease affected structural network disruption and cortical thinning in distinct brain areas, and contributed to declines in corresponding cognitive domains in cognitively impaired patients. 2, 4, 9 However, little remains known about the effect of co-occurring AD and cerebrovascular disease pathologies on brain functional network changes.
Intrinsic functional connectivity (FC), which measures the temporal synchrony between low-frequency oscillations in blood oxygenation level-dependent fMRI signals under taskfree conditions, offers a promising tool for the understanding of disease-related changes in brain functional networks. Using such methods, studies have similarly demonstrated differential effects of AD and cerebrovascular disease pathologies on FC. AD, on its own, is prominently associated with disruptions in the default mode network (DMN), [10] [11] [12] a network linked to autobiographical and episodic memory retrieval. 13 Patients with AD have consistently shown reduced DMN FC compared to healthy controls. [10] [11] [12] Importantly, DMN disruptions are apparent at prodromal AD stages, with crosssectional studies reporting both increases and decreases in DMN FC of patients with mild cognitive impairment (MCI) [14] [15] [16] as well as cognitively normal elderly with significant Aβ burden. 17, 18 Increased Aβ burden was also associated with reduced whole-brain FC to the posterior cingulate cortex (a key DMN region) in a cross-sectional cohort comprising healthy participants and those with MCI. 19 Cerebrovascular disease, on the other hand, is primarily associated with disruptions in the executive control network (ECN), Glossary Aβ = β-amyloid; AD = Alzheimer disease; ADL = activities of daily living; aMCI = amnestic mild cognitive impairment; DMN = default mode network; ECN = executive control network; FC = functional connectivity; FLAIR = fluid-attenuated inversion recovery; GMV = gray matter volume; MCI = mild cognitive impairment; MNI = Montreal Neurological Institute; PiB = Pittsburgh compound B; SNSB = Seoul Neuropsychological Screening Battery; SUVR = standardized uptake value ratio; svMCI = subcortical vascular mild cognitive impairment; VOI = volume of interest. a frontoparietal network associated with executive function. Studies have linked cerebrovascular disease to declines in executive function, 20 reduced frontal lobe metabolism, 21 and disrupted FC in frontoparietal regions. 22, 23 While few studies have examined FC changes in patients with co-occurring AD and cerebrovascular disease pathologies, there is some cross-sectional evidence supporting the presence of such divergent FC effects in these patients. In one study, patients with Aβ-positive AD and patients with Aβ-negative subcortical vascular dementia showed diseasespecific vulnerability in DMN FC (i.e., reduced posterior FC in AD, reduced frontal FC in subcortical vascular dementia), while patients with subcortical vascular dementia showed declines in ECN FC. Further, patients with mixed dementia (Aβ-positive subcortical vascular dementia) exhibited greater disruptions in DMN and ECN FC compared to patients with AD and patients with subcortical vascular dementia. 24 In another study, patients with AD without cerebrovascular disease exhibited reduced DMN FC compared to those with cerebrovascular disease, while patients with AD and cerebrovascular disease showed increased frontal ECN FC compared to those without cerebrovascular disease. These changes in the ECN were also mirrored in patients with cognitive impairment but no dementia with and without cerebrovascular disease, indicating that the divergent FC changes were present even at early disease stages. 25 However, while these studies provide insight on the differential FC effects of AD and cerebrovascular disease in crosssectional cohorts, the influence of AD and cerebrovascular disease pathologies on the longitudinal trajectory of FC changes in patients with MCI remains unknown. Our study thus sought to examine the effects of baseline Aβ and cerebrovascular disease markers on longitudinal functional network changes in patients with amnestic MCI (aMCI) and patients with subcortical vascular MCI (svMCI), which are often regarded as prodromal stages of AD and subcortical vascular dementia, respectively. Specifically, we focused on FC changes in the DMN and ECN, 2 key networks implicated in AD and cerebrovascular disease. Given past evidence, we hypothesized that the 2 MCI subtypes with and without Aβ burden would exhibit divergent FC changes over time. Aβ burden, as measured by Pittsburgh compound B (PiB) standardized uptake value ratio (SUVR), would be associated with longitudinal DMN FC declines. Conversely, cerebrovascular burden, as measured by lacune number, would be primarily associated with longitudinal ECN FC changes.
Methods

Participants
We prospectively recruited 105 patients with MCI from September 2008 to September 2011 at Samsung Medical Center in Seoul, South Korea. Diagnoses of MCI were made using Petersen criteria, 26 with the following modifications 27 : (1) subjective cognitive complaint by patients or caregivers;
(2) normal activities of daily living (ADL) determined clinically and according to the instrumental ADL scale 28 ; (3) objective cognitive impairment below the 16th percentile (i.e., below 1 SD) of education-and age-matched norms in at least one of 4 domains (memory, visuospatial, language, or frontal-executive function) of the Seoul Neuropsychological Screening Battery (SNSB) 29 ; and (4) no dementia.
Patients were further diagnosed with svMCI if they had subcortical vascular features defined as significant ischemia on MRI and focal neurologic symptoms or signs such as corticobulbar signs, pyramidal signs, or parkinsonism. 30 Significant ischemia was defined as severe white matter hyperintensities on fluid-attenuated inversion recovery (FLAIR) images meeting the following criteria: (1) white matter hyperintensities ≥10 mm in the periventricular white matter and (2) white matter hyperintensities ≥25 mm in the deep white matter, which is consistent with an extensive or diffusely confluent lesion. Patients were further diagnosed with aMCI if they showed objective impairment below the 16th percentile of education-and age-matched norms on either the visual or verbal memory domain of the SNSB and did not have significant ischemia on MRI.
Patients were evaluated by clinical interviews and neuropsychological and neurologic examinations at baseline. All patients underwent laboratory tests including a complete blood count, syphilis serology, vitamin B 12 /folate, blood chemistry, and thyroid function tests. Absence of structural lesions including brain tumors, vascular malformation, territorial cerebral infarction. and hippocampal sclerosis was confirmed using MRI. Patients in this cohort were followed up annually with neuropsychological tests and brain MRI scans for up to 4 years. In total, there were 91 patients (33 aMCI and 58 svMCI) who had at least 2 timepoints of brain MRI (aMCI: 29 with 2 timepoints, 4 with 3 timepoints; svMCI: 10 with 2 timepoints, 14 with 3 timepoints, 34 with 4 timepoints).
Standard protocol approvals, registrations, and patient consents
The study protocol was approved by the Institutional Review Board of Samsung Medical Center, and written informed consent was obtained from all patients.
Image acquisition MRI acquisition
We acquired standardized T2-weighted, T1-weighted, FLAIR, and task-free fMRI from patients at Samsung Medical Center using a Philips Achieva 3.0 T MRI scanner (Philips Healthcare, Best, the Netherlands). Imaging measures for the MRI were as follows: (1) T1-weighted: repetition time = 9.9 ms, echo time = 4.6 ms, flip angle = 8°, voxel resolution = 0.5 mm 3 isotropic, matrix size = 240 × 240 pixels, reconstructed to 480 × 480 over a field of view of 240 mm; (2) T2weighted: axial slice thickness = 5.0 mm, interslice thickness = 1.5 mm, repetition time = 3,000 ms, echo time = 80 ms, flip angle = 90°, and matrix size = 512 × 512 pixels; (3) FLAIR: axial slice thickness = 2 mm, no gap, repetition time = 11,000 ms, echo time = 125 ms, flip angle = 90°, and matrix size = 512 × 512 pixels; and (4) task-free fMRI: echoplanar imaging sequence (5 minutes, 100 volumes), repetition time = 3,000 ms, echo time = 35 ms, flip angle = 90°, and voxel resolution = 1.7 × 1.7 × 4 mm 3 . During the fMRI scan, participants were instructed to fixate on a centrally located white crosshair against a black background. A CT scan was then performed for attenuation correction 60 minutes after injection, followed by a 30-minute emission static PET scan. We reconstructed attenuation-corrected PET images from the CT data using an iterative reconstruction method following previous approach. 31 Image processing [ 11 
C]PiB-PET data analysis
PiB-PET images were first coregistered to the corresponding T1-weighted images, and subsequently normalized to Montreal Neurological Institute (MNI) 152 (MNI152) standard space. Regional values of PiB retention on the normalized PiB images were then obtained using an automated volume-of-interest (VOI) analysis. Following previous protocol, 2,32,33 28 cortical VOIs were selected from the automated anatomical labeling atlas 34 and comprised the bilateral frontal, parietal, lateral temporal, occipital, and posterior cingulate cortex. We computed regional SUVRs by dividing each VOI uptake ratio by the mean uptake of the cerebellar cortex (cerebellum crus1 and crus2) (reference region). To obtain a measure of Aβ burden, global PiB SUVR was calculated as the volume-weighted average uptake ratio of the above 28 VOIs. Patients were categorized into PiB-positive (PiB+) or PiB-negative (PiB−) using a global PiB SUVR cutoff value of 1.5. 31
Assessment of lacune number
We defined lacunes as small lesions (≤15 mm and ≥3 mm in diameter) with high signal on T2-weighted images, low signal on T1-weighted images, and a perilesional halo on FLAIR images according to Standards for Reporting Vascular Changes on Neuroimaging (STRIVE) criteria. 35 The number of lacunes was manually counted by 2 neurologists (κ value = 0.78).
Functional imaging
Preprocessing of task-free fMRI was performed using the Analysis of Functional NeuroImages software 36 and FMRIB Software Library 37 in accordance with previous protocol. 25 The preprocessing procedure involved the following: (1) discarding of first 5 volumes for magnetic field stabilization;
(2) slice-time and motion correction; (3) time series despiking; (4) grand mean scaling; (5) spatial smoothing using a 6-mm full-width at half-maximum Gaussian kernel; (6) bandpass temporal filtering at 0.009-0.1 Hz; (7) removal of linear and quadratic trends; (8) coregistration to T1-weighted images using boundary-based registration and subsequently nonlinear registration of fMRI to MNI152 space; and (9) regression of global signal, white matter, CSF, and 6 motion parameters from the preprocessed fMRI.
Structural imaging
Gray matter volume (GMV) probability maps at each timepoint were obtained from structural images using a longitudinal voxel-based morphometry protocol following previous work. 38 This protocol used the VBM8 toolbox (Structural Brain Mapping Group; dbm.neuro.uni-jena.de/software/) in Statistical Parametric Mapping (SPM12; Wellcome Trust Centre for Neuroimaging; fil.ion.ucl.ac.uk/spm/software/spm12/) and included (1) realignment of intraparticipant images across timepoints; (2) creation of participant-specific mean reference images; (3) intraparticipant signal inhomogeneity correction using the reference image; (4) segmentation into gray matter, white matter, and CSF using the adaptive Maximum A Posterior method, which does not require a priori information about tissue probabilities; (5) creation of a customized template using nonlinear diffeomorphic anatomical registration through exponentiated lie algebra (DARTEL) registration of the affine-registered segmented images; (6) registration of reference GMV and white matter volume probability maps to the customized template in standard MNI152 space; (7) application of registration in step 6 to individual GMV and white matter volume probability maps at each timepoint; and (8) nonlinear modulation of preprocessed images by multiplying voxels with the nonlinear component of the Jacobian determinant to correct for individual brain sizes.
Derivation of FC matrices and mean nodal GMV
DMN and ECN FC matrices were generated separately for each participant at each timepoint. To obtain these FC matrices, we first identified regions of interest (nodes) pertaining to the DMN (18 nodes) and ECN (22 nodes) based on a previous FC-based parcellation scheme 39 To obtain participant-specific mean GMV for each node, GMV probability values from individual GMV maps were averaged across all voxels within each node.
Statistical analyses
From the dataset of 91 patients with at least 2 timepoints of MRI data, we further excluded those whose data failed the motion criteria (maximum absolute displacement <3 mm, maximum relative displacement <1 mm). This gave rise to a subset of 85 patients ( timepoints]) whose data were used for further statistical analyses (table 1). As age and education differed between the groups, these variables were added as nuisance covariates in all analyses.
Effect of time on brain FC
Linear mixed effects models were used to examine longitudinal FC changes for each group (aMCI PiB−, aMCI PiB+, svMCI PiB−, svMCI PiB+) separately. Analyses were performed using the lme4 40 package in R 3.0.3 41 with Rstudio. 42 In these 4 separate models, time (i.e., number of years from baseline) was modeled as a random effect (random intercepts and slopes) for each participant, while baseline age, sex, and years of education were modeled as fixed effects. The linear mixed model for the effects of time on FC is as follows:
where Y ij denotes the edgewise FC for each participant j at timepoint i, γs denote the estimated fixed effect coefficients, μs denote the estimated random effect coefficients, and r ij denotes the residual for each participant j at timepoint i.
Difference in effect of time on FC between aMCI PiB+ and svMCI PiB2 patients
To further test our hypothesis of divergent effects of Aβ and cerebrovascular disease burden on FC, we in addition examined differences in the effect of time on FC between the 2 groups who likely did not have mixed pathology-aMCI PiB+ and svMCI PiB−. The model included time as random effect, and group (aMCI PiB + vs svMCI PiB−), baseline age, sex, and education as fixed effects. In addition, the effect of time was allowed to vary as a function of group (i.e., group by time interaction). The linear mixed model is thus:
Effect of baseline PiB SUVR and lacune number on longitudinal changes in FC
Finally, instead of separating individuals into PiB+ and PiB− groups, we examined the effects of baseline PiB SUVR and lacune number as continuous variables on longitudinal edgewise FC changes. PiB SUVR and lacune numbers were log-transformed as they had skewed distributions. Separate linear mixed models were performed for patients with svMCI, aMCI, and across all patients. In these 3 models, we modeled time as random effect, and sex, education, age, baseline PiB SUVR, and baseline lacune number as fixed effects, as follows:
For all statistical analyses, both uncorrected (p < 0.005) and multiple comparisons corrected (false discovery rateadjusted p < 0.05) results were reported. In addition, to determine if GMV changes or conversion status accounted for the observed findings, we repeated the above analyses with mean nodal GMV or conversion status included as covariates (e-Methods, doi.org/10.5061/dryad.v5h2fd7).
Data availability
The data that support the findings of this study are available upon request from the corresponding authors (J.Z. and S.W.S.). The data are not publicly available due to institute policy.
Results
Effect of Aβ burden on longitudinal DMN and ECN FC changes
We first examined longitudinal FC changes for each of the 4 groups separately. In PiB+ groups (i.e., aMCI PiB+ and svMCI PiB+), DMN FC was found to decrease with time. In contrast, PiB− groups (i.e., svMCI PiB− and aMCI PiB−) showed predominantly DMN FC increases with time ( figure 1A and 
Validation analyses
For all analyses, similar findings were obtained even after controlling for GMV or conversion status, suggesting that the effects of Aβ and cerebrovascular disease burden on longitudinal DMN and ECN FC changes are unlikely due to changes in GMV or conversion status (tables e-2 to e-7, doi.org/10. 5061/dryad.v5h2fd7).
Discussion
We sought to examine the effects of Aβ and cerebrovascular disease burden on longitudinal changes in DMN and ECN FC of patients with MCI. We showed that Aβ burden was asso- U-shape and inverse U-shape relationships with longitudinal ECN FC changes in patients with svMCI. Taken together, our longitudinal findings extend previous cross-sectional findings and support the divergent effects of Aβ and cerebrovascular burden on DMN and ECN FC, respectively.
Aβ burden is associated with longitudinal DMN FC declines in both aMCI and svMCI
Consistent with previous evidence supporting DMN involvement at prodromal stages of AD, 17, 18 is consistent with studies showing that Aβ is associated with initial hyperconnectivity followed by subsequent hypoconnectivity in the DMN of preclinical and prodromal AD. 43, 44 One possible account for this hyperconnectivity/ hypoconnectivity phenomenon is that the early presence of soluble Aβ oligomers (undetectable by Aβ PET imaging) prior to the formation of Aβ plaques induces initial abnormal hyperactivity, with silencing of brain circuits only occurring at later disease stages. 45 Alternatively, the initial FC increase could represent compensatory increases in use of neural resources to cope with the early neuronal injury. As Aβ burden continues to increase, FC eventually declines when neural resource loss reaches a threshold and increased FC is no longer a viable response to the insult. 46 Further, tau has recently been proposed to moderate the relationship between Aβ burden and FC changes. 44 Future studies examining the effects of both tau and Aβ on FC might shed more light on the factors contributing to the hyperconnectivity/hypoconnectivity phenomena in early AD.
While Aβ burden was observed to be associated with longitudinal ECN FC declines in aMCI as well, the effects were less Interestingly, we note that the spatial pattern of Aβ-related DMN FC disruptions differed between the 2 subtypes. In particular, patients with aMCI showed Aβ-related DMN FC disruptions in edges involving the temporal lobes, while patients with svMCI showed declines in edges involving the posterior cingulate cortex. These differences in spatial vulnerability patterns between the 2 subtypes might be related to differences in their Aβ distribution patterns. One study examining PiB retention in MCI subtypes showed that svMCI PiB+ patients had increased retention in occipital, precuneus, and posterior cingulate cortices, while patients with aMCI PiB+ had increased retention in striatum and temporal areas. 47 Future research could explore the relationship between Aβ distribution and FC in the 2 subtypes and examine how they might differentially affect cognition. However, while these past studies have consistently found ECN FC disruptions, findings remain mixed in regards to whether these FC changes are increases or decreases. 22, 23, 25, 48 In our study, we similarly found a mixture of increases and decreases in longitudinal ECN FC as a function of cerebrovascular disease burden. Several possible explanations account for these mixed changes. One possibility is that cerebrovascular-related changes in ECN FC mainly follow an inverted U-shape trajectory, akin to the hyperconnectivity/ hypoconnectivity phenomena observed for Aβ burden in early AD. Initial ECN FC increases may be a compensatory mechanism to cope with cerebrovascular disease burden, with FC decreasing subsequently as increasing burden eventually results in functional network breakdown. Such compensatory mechanisms might be related to cerebrovascular diseaserelated changes of the underlying white matter networks. In response to ischemic injury, oligodendrocyte precursor cells can multiply and differentiate into mature oligodendrocytes to remyelinate axons 49 (resulting in compensatory FC increases), although prolonged ischemia may eventually damage these precursor cells and result in ineffective remyelination 50 (and subsequently FC decreases). Alternatively, ECN FC increases might be aberrant. Previous studies have linked greater lacune numbers to decreased integration and increased segregation of white matter networks, which in turn related to poorer cognitive performance. 51 This increased network segregation could be due to aberrant attempts to remyelinate in response to injury, leading to greater but more inefficient local, within-network connections, and hence increased within-network FC. The structural network segregation increases may hence underlie within-network ECN FC increases, which may be accompanied by information integration loss of ECN with other networks.
Finally, the mixed findings might be due to differences in the type and location of cerebrovascular lesions across different studies. Different types of cerebrovascular lesions (e.g., lacunes, microbleeds) might have different etiologies 35, 52 and hence affect FC differentially. Further, different lesion locations might be associated with decline in different cognitive functions. 53 Future studies could examine how the type and location of cerebrovascular lesions could differentially affect FC changes in prodromal and clinical dementia.
Limitations
Due to the moderate sample size (30 aMCI and 55 svMCI), we were unable to examine interaction effects between PiB SUVR and lacune number, or explore the effect of multiple variables (e.g., lesion location) on longitudinal FC changes. In addition, the follow-up period for patients was relatively short (2-4 years). As such, nonlinear longitudinal FC changes cannot be reliably tracked. Future studies with larger sample size and longer follow-up periods would allow for the examination of nonlinear trends as well as the effects of a wider range of variables (e.g., interaction effects, various pathologies) on FC in prodromal and clinical dementia. Finally, we only examined the effects of Aβ and cerebrovascular disease burden on FC within the DMN and ECN, given their key roles in AD and cerebrovascular disease, respectively. Future studies examining whole-brain FC changes could provide a more comprehensive overview of the effects of AD and cerebrovascular disease burden on functional brain networks.
We showed that Aβ and cerebrovascular disease burden had divergent effects on longitudinal DMN and ECN FC changes in both aMCI and svMCI. Specifically, Aβ burden was associated with longitudinal declines in DMN FC, while cerebrovascular disease burden was associated with longitudinal disruptions in ECN FC. Our results suggest that longitudinal changes in DMN and ECN FC reflect the underlying pathology and may be used to track early changes in AD and cerebrovascular disease.
